FridayMar 13, 2020 12:16 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) Revolutionizing Traditional Organic Tea

Champignon Brands (CSE: SHRM), a wellness company specializing in the formulation and distribution of a suite of medicinal mushroom-infused products, is revolutionizing the traditional organic tea theory with its Vitality SuperTea offerings. A recent article discussing the company reads, “SHRM is building a reputation as a leader in the burgeoning craft mushroom vertical space. The company’s flagship brand — Vitality SuperTeas — offers a line of proprietary teas formulated with the goal of revolutionizing conventional organic tea through the infusion of a proprietary blend of artisanal mushrooms with medicinal properties. . . . Each of Champignon’s Vitality SuperTeas (http://ibn.fm/kzeU6) is carefully…

Continue Reading

FridayMar 13, 2020 12:00 pm

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Launches New Brand, Extends Portfolio

PLUS was largest, best-selling infused gummies brand in California in 2019 Launch of new Plus Products CBDRelief brand extends portfolio into wellness and relief market Company plans another successful launch in strategic pursuit to become the world’s strongest cannabis brand Kleenex, Xerox, Coca-Cola: Through hyper-focused brand cultivation, these companies’ products have become symbols of their respective categories. As it strives to become the preferred edibles brand in the world, Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) is channeling this strategy, choosing a core product on which to build a strong brand name before branching out. As a result, Plus has…

Continue Reading

FridayMar 13, 2020 11:29 am

Predictive Oncology Inc. (NASDAQ: POAI) AI/ML Expertise, Recent Acquisition Invaluable Resources in Search for New Anti-Virals, Vaccines

POAI positioned as leader in using data, artificial intelligence in search for novel effective treatments Planned acquisition provides Predictive Oncology with CoRE(TM), a proven machine-learning framework Uniting CoRE with proprietary PDx tumor-profiling platform and tumor-data database creates one-of-a-kind, end-to-end “discovery machine” With its recent proposed acquisition of Carnegie Mellon spin-out Quantitative Medicine, Predictive Oncology Inc. (NASDAQ: POAI), a leader in using data and artificial intelligence (AI) to develop personalized cancer therapies, demonstrates its strong position in assisting in the search for new anti-cancers, anti-virals, antibiotics and vaccines. POAI’s expertise in this area is particularly relevant in light of the current…

Continue Reading

FridayMar 13, 2020 11:00 am

QualityStocksNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) to Report Q4, Full Year 2019 Financial Results and Host Earnings Call

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced that it will report its fourth quarter and full year 2019 unaudited financial results before the U.S. markets open on Monday, March 23, 2020. According to the update, Blue Hat's management will host an earnings conference call on March 23 at 8:00 AM ET (8:00 PM Beijing/Hong Kong Time). Interested parties may join the call by dialing +1-845-675-0437 (U.S./International), +852-3018-6771 (Hong Kong) or 400-620-8038 (Mainland China) and entering passcode 4375563. A conference replay…

Continue Reading

FridayMar 13, 2020 10:55 am

QualityStocksNewsBreaks – OriginClear, Inc. (OCLN) CEO Discusses Water-Distressed Real Estate on MoneyTV with Donald Baillargeon

OriginClear (OTCQB: OCLN), a leading provider of water treatment solutions, was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households in more than 75 countries, covers money-focused topics and features various companies and in-depth CEO and executive interviews offering insights into operations and future outlooks. Among other highlights, this week’s program featured OriginClear CEO Riggs Eckelberry as he discussed potential future opportunity in water-distressed real estate. To view the full press release, visit http://ibn.fm/gcasp About OriginClear, Inc. Water is our planet’s most valuable resource, and the mission of OriginClear…

Continue Reading

FridayMar 13, 2020 10:22 am

QualityStocksNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Unveils New CBD Products on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives that offer insights into various companies and their operations and future outlooks. Among other highlights, this week’s program featured CIIX CEO Warren Wang as he discussed the launch of two new products through the company’s China-based subsidiary, CBD Biotech. Wang unveiled details, referring to a recent press release, and further discussed the company’s new hemp-infused spray, designed to create an…

Continue Reading

FridayMar 13, 2020 10:15 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Successful NYC Trip on MoneyTV with Donald Baillargeon

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint CEO Greg Lambrecht discussed a successful NYC trip. “As a lot of the shareholders know, this is going to be two years now that SinglePoint is fully reporting and, as discussed before, it looks like we’re going to show revenues…

Continue Reading

FridayMar 13, 2020 9:39 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Financial Results for Q4, Full Year 2019

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, on Thursday announced financial results for the fourth quarter and full year 2019. According to the update, Foresight ended the fourth quarter of 2019 with $10.1 million in cash and short-term deposits. The company reported GAAP net loss of $4.37 million and non-GAAP net loss of $4 million for the fourth quarter of 2019. “Foresight completed 2019 with a series of positive developments, as our QuadSight(R) vision system continued to gain commercial interest as well as award recognition,” Foresight’s CEO Haim Siboni said in the news release.…

Continue Reading

FridayMar 13, 2020 9:30 am

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Provides Update on Technology Licensing Agreement, Reports Changes to Executive Team

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), an integrated oil ‎company focused on the development and implementation of its proprietary oil-‎extraction and remediation technologies, on Thursday provided an update regarding progress on the licensing of its proprietary oil-sands extraction ‎technology. In July 2019, the company entered into a non-exclusive technology licensing agreement with Valkor LLC granting Valkor the right to use Petroteq’s proprietary patented technology to engineer, construct, operate and finance oil sands extraction plants. Per the agreement, Valkor would pay the company a non-refundable license fee of US$2 million per plant in two equal payments, the first of which being…

Continue Reading

ThursdayMar 12, 2020 11:30 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Launch of New AI Platform for Vaccine and Drug Development Targeting COVID-19, MERS and SARS

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its plans to launch a new AI platform for vaccine and drug development targeting Coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS and SARS) through an operating agreement with Soluble Therapeutics.  According to the update, POAI has also signed a letter of intent with InventaBioTech to acquire Soluble Therapeutics, its assets and its HSCTM Technology. As global health experts predict an ever-increasing number of viral outbreaks like COVID-19, POAI is taking proactive measures to be part of the solution by…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered